⟵ Back to Search Results

BGB-290-AU-002

Completed

Phase 1a/1b BGB-290 for Advanced Solid Tumors.

Beigene Study ID info

BGB-290-AU-002

ClinicalTrials.gov ID info

NCT02361723

Study Overview

Sex: All

Age: 18 Years / 99 Years

No Study Documents

Study Overview

Sex: All

Age: 18 Years / 99 Years

No Study Documents